MedPath

Natamycin

Generic Name
Natamycin
Brand Names
Natacyn
Drug Type
Small Molecule
Chemical Formula
C33H47NO13
CAS Number
7681-93-8
Unique Ingredient Identifier
8O0C852CPO
Background

Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. [PubChem]

Indication

For the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.

Associated Conditions
Fungal blepharitis, Fungal conjunctivitis, Fungal infections of the cornea

Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis

Phase 2
Not yet recruiting
Conditions
Fungal Keratitis
Interventions
First Posted Date
2024-06-18
Last Posted Date
2024-06-18
Lead Sponsor
IVIEW Therapeutics Inc.
Target Recruit Count
60
Registration Number
NCT06463678

The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study

First Posted Date
2022-12-19
Last Posted Date
2024-01-25
Lead Sponsor
Alexandria University
Target Recruit Count
123
Registration Number
NCT05655689
Locations
🇪🇬

Cornea Outpatient Clinic at Alexandria Main University Hospital, Alexandria, Egypt

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction

Phase 3
Active, not recruiting
Conditions
Acanthamoeba Keratitis
Fungal Keratitis
Interventions
First Posted Date
2021-11-05
Last Posted Date
2025-01-31
Lead Sponsor
University of California, San Francisco
Target Recruit Count
330
Registration Number
NCT05110001
Locations
🇮🇳

Aravind Eye Care System, Madurai, Tamil Nadu, India

🇧🇷

Federal University of São Paulo, São Paulo, Brazil

Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers

Phase 3
Completed
Conditions
Fungal Keratitis
Corneal Ulcer
Interventions
First Posted Date
2016-04-07
Last Posted Date
2019-10-01
Lead Sponsor
University of California, San Francisco
Target Recruit Count
70
Registration Number
NCT02731638
Locations
🇮🇳

Aravind Eye Hospitals, Pondicherry, Tamil Nadu, India

🇺🇸

Francis I. Proctor Foundation at UCSF, San Francisco, California, United States

Mycotic Ulcer Treatment Trial I

Phase 3
Completed
Conditions
Eye Infections, Fungal
Corneal Ulcer
Interventions
First Posted Date
2009-10-16
Last Posted Date
2018-08-01
Lead Sponsor
University of California, San Francisco
Target Recruit Count
323
Registration Number
NCT00996736
Locations
🇮🇳

Aravind Eye Hospital, Pondicherry, Tamil Nadu, India

🇮🇳

Aravind Eye Hospitals, Madurai, Tamil Nadu, India

🇺🇸

Proctor Foundation, UCSF, San Francisco, California, United States

Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer

Phase 1
Completed
Conditions
Fungal Keratitis
Interventions
Procedure: Corneal de-epithelialization
First Posted Date
2007-11-14
Last Posted Date
2018-08-07
Lead Sponsor
University of California, San Francisco
Target Recruit Count
120
Registration Number
NCT00557362
Locations
🇮🇳

Aravind Eye Hospital, Pondicherry, Tamil Nadu, India

A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine

First Posted Date
2007-08-15
Last Posted Date
2014-12-04
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
78
Registration Number
NCT00516399
© Copyright 2025. All Rights Reserved by MedPath